Get started
Author

K W Locke

Observed names: K. Locke, K. W. LOCKE, K. W. Locke, K.W. Locke
ORCID: 0000-0002-3413-7334
Observed ORCID: 0000-0002-3413-7334
OpenAlex ID: A5067325888
Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's disease.
1998 · P J Blanchet, J Fang, et al. · PubMed · 79
Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
1986 · K W Locke, S G Holtzman · Journal of Pharmacology and Experimental Therapeutics · 40
Neural Mechanisms of Drug Stimuli: Experimental Approaches
1988 · S. G. Holtzman, K. W. Locke · Springer eBooks · 38
The D1 Agonist Dihydrexidine Releases Acetylcholine and Improves Cognition in Rats
1996 · T. D. STEELE, D. B. HODGES, et al. · Annals of the New York Academy of Sciences · 29
Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
1986 · K W Locke, S G Holtzman · Journal of Pharmacology and Experimental Therapeutics · 27
Cardiorespiratory effects of the novel opioid analgesic HP 736 in the anesthetized dog and conscious goat.
1992 · J W Hubbard, K W Locke, et al. · Journal of Pharmacology and Experimental Therapeutics · 8
A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of MN-029, a novel vascular disrupting agent (VDA), in patients (pts) with advanced solid tumors
2006 · A. D. Ricart, M. Cooney, et al. · Journal of Clinical Oncology · 7
Characterization of the discriminative stimulus effects of physostigmine in the rat.
1989 · K W Locke, B Gorney, et al. · Journal of Pharmacology and Experimental Therapeutics · 4
1001 POSTER Assessment of pharmacodynamic effect in a phase I study of MN-029, an IV administered vascular disruptive agent, using dynamic contrast-enhanced MRI
2007 · E. Ashton, S. Remick, et al. · European Journal of Cancer Supplements · 1
359 POSTER Pharmacokinetic and pharmacodynamic effects of MN-029, a novel vascular disrupting agent (VDA), in patients (pts) with advanced solid tumors
2006 · A. Ricart, M. Cooney, et al. · European Journal of Cancer Supplements · 1
Phase I study of MN-001, an oral anti-inflammatory agent for the treatment of asthma
2005 · K.W. Locke · Journal of Allergy and Clinical Immunology · 1
Effects Of MN-001 In Patients With Mild-to-moderate Asthma In A Randomized, Double-blind And Placebo-controlled Phase II Study
2007 · W.W. Busse, H.S. Nelson, et al. · Journal of Allergy and Clinical Immunology
PDF
Beneficial effects of citicoline in experimental allergic encephalomyelitis in rats and mice
1999 · Nick M. Clayton, K W Locke, et al.
Influence of different routes of administration on the cardiovascular effects of dihydrexidine (DHX) in rats
1998 · Ting-Yi Wu, K W Locke, et al. · The FASEB Journal
Works count: 14
Citation count: 235
H-index: 7
I10-index: 5
Year
Topic
Type